Month: April 2022

Republic Bank Republic Bank Hires Donald Greenleaf as Vice President, Commercial Lending for Bucks CountyPHILADELPHIA, April 20, 2022 (GLOBE NEWSWIRE) — Republic First Bancorp, Inc. (NASDAQ: FRBK), the parent company of Republic Bank, today announced the hiring of Donald Greenleaf as Vice President, Commercial Lending for Bucks County. In his role, Greenleaf will be responsible for growing the bank’s commercial loan portfolio as it continues to expand its presence in this key market. Greenleaf comes to Republic Bank with 25 years of experience in the banking industry. Most recently, he served as a Vice President at Firstrust Bank where he generated new business on both the commercial and retail sides and played a crucial role in growing deposits and loans. Greenleaf spent the first two decades of his career rising through the...

ATLANTA, April 20, 2022 (GLOBE NEWSWIRE) — Trust Stamp (Nasdaq: IDAI, Euronext Growth: AIID ID), the Privacy-First Identity CompanyTM providing AI-powered trust and identity services used globally across multiple sectors, today announces that Gareth Genner, CEO of Trust Stamp, will be speaking on the use of identity tokenization for streamlined inter and intra-metaverse transactions during a virtual session hosted by the Rutgers Law School FinTech and Blockchain Collaboratory (the “Collaboratory”). Those interested in attending are invited to join the virtual event taking place on April 22, 2022 at 12pm ET using this link. Genner joins the Collaboratory to explore the use of irreversible tokenization to establish a trusted “MetaPresence” identity that enables privacy-protected storage, access to, and exchange of digital assets,...

Data from studies evaluating ibrexafungerp in serious fungal infections will be presented JERSEY CITY, N.J., April 20, 2022 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced the presentation of interim data from its ongoing Phase 3 FURI and CARES studies, as well as multiple posters regarding studies of ibrexafungerp at the 32nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) being held in Lisbon, Portugal, April 23-26, 2022. “We are pleased to have this opportunity to share our most recent research analyses and hear updates from our colleagues regarding efforts by the global scientific community to treat serious infectious diseases,” said David Angulo, M.D.,...

VANCOUVER, British Columbia, April 20, 2022 (GLOBE NEWSWIRE) — Victory Square Technologies Inc. (“Victory Square”) (CSE:VST) (OTCQX:VSQTF) (FWB:6F6), a Venture Studio providing investors with VC-level investment access to the biggest ideas developed by the top startups from around the world, is pleased to co-host a Fintech pitch battle with The Holt Xchange,  a Canadian based global early-stage VC fund, on Tuesday, May 17th, 2022 from 3:30-5:30 PM PST. The event will consist of five early-stage fintechs who will present their company to an audience of investors and advisors attending the live event. The audience will be able to engage in live voting and provide their feedback, in addition to the four judges who will be asking the teams questions during the Q&A. “Investing in the next generation of business leaders is at the...

NEWARK, Calif., April 20, 2022 (GLOBE NEWSWIRE) — Rain Therapeutics Inc. (NasdaqGS: RAIN), (“Rain”), a late-stage company developing precision oncology therapeutics, today announced it will report financial results for the first quarter ended March 31, 2022 and highlights of recent progress on Wednesday, May 4, 2022. On that day, management will host a conference call and webcast at 2:00 pm PT (5:00 pm ET) to discuss the Company’s business and financial results. Conference Call and Webcast Details: Date: May 4, 2022Time: 2:00-3:00 pm PT (5:00-6:00 pm ET)Dial In Numbers: 1 (877) 300-8521 (U.S. Toll Free) / 1 (412) 317-6026 (International) Conference ID: 10166166 Webcast Link: https://services.choruscall.com/mediaframe/webcast.html?webcastid=yOa8KoUv Replay of the call will be available by visiting the “Events” section...

PRINCETON, N.J., April 20, 2022 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the first quarter of 2022 after the market close on Thursday, May 5th, 2022. Company management will host a conference call to discuss financial results at 5:00 p.m. ET. Investors interested in listening to the conference call may do so by dialing (833) 360-0946 for domestic callers or (914) 987-7661 for international callers, followed by Conference ID: 1290087. A live and archived webcast of the event will be available on the “Investors” section of the Certara website at https://ir.certara.com/. About CertaraCertara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development....

NEW YORK, April 20, 2022 (GLOBE NEWSWIRE) — Sportradar Group AG (NASDAQ:SRAD) (“Sportradar” or “the Company”), will release its financial and operating results for the first quarter fiscal 2022, ending March 31, 2022, on Wednesday, May 18, 2022. Sportradar will also host a conference call to discuss these results at 8:00 a.m. eastern time on Wednesday, May 18, 2022. Those wishing to participate via webcast should access the earnings call through Sportradar’s Investor Relations website at https://investors.sportradar.com/. An archived webcast with the accompanying slides will be available at the Company’s investor relations website for one year after the conclusion of the live event. Those wishing to participate via telephone may dial in at 1-855-725-1617 (USA) or +1-509-960-9043 (International), passcode 4366155. A replay of the...

Presentation to review historic issues related to glaucoma therapies and how these may be addressed through the use of Optejet® technology NEW YORK, April 20, 2022 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print (MAP™) investigational products, today announced that Dr. Sean Ianchulev, Chairman, Chief Executive Officer and Chief Medical Officer, will deliver a presentation at Eyecelerator, which is being held on Thursday, April 21 in Washington, DC. “I am very pleased to have this opportunity to present at this year’s Eyecelerator conference and highlight new data demonstrating the many aspects of our proprietary Optejet® technology. We believe the Optejet® coupled with an effective IOP lowering medication may be able to address the...

Global study will evaluate UX143 in pediatric and young adult patients ages 5 to NOVATO, Calif., April 20, 2022 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, today announced the first patient has been dosed in a clinical study for the treatment of Osteogenesis Imperfecta (OI) in patients ages 5 to